AKT1 and breast cancer: Consistently, it has been reported that expression of the mTORc2 core component Rictor is significantly up-regulated in invasive breast cancer specimens, which promotes Akt-dependent tumor progression in HER2-amplified breast cancers (Morrison Joly et al., 2016).